These studies investigated feeding responses to indirect activation of parabrachial cannabinoid CB1 receptors. Arachidonoyl serotonin (AA5HT), an inhibitor of the endocannabinoid degradative enzyme, fatty acid amide hydrolase (FAAH), was infused into the parabrachial nucleus of Male Sprague-Dawley rats and intakes of highfat/sucrose pellets and standard rodent chow were subsequently evaluated under various feeding schedules. FAAH blockade stimulated the intake of high-fat/sucrose pellets that were presented daily for 4hr during the light period, with compensatory decreases in the consumption of standard chow during the ensuing 20hr. These diet-selective changes repeated on the next day, indicating a shift in feeding towards the more palatable diet that lasted for 48hrs after a single infusion. The cannabinoid CB1 receptor antagonist, AM251, blocked the orexigenic actions of AA5HT, implicating CB1 receptors in mediating the feeding responses to FAAH inactivation. When the feeding schedule was reversed, AA5HT produced nominal increases in the consumption of standard chow for the 4hr access period, but substantial increases in the intake of high-fat/sucrose during the following 20hr interval. When presented with only high-fat/sucrose for 24hr, AA5HT increased 24hr food intake. In contrast, when given 24hr access only to standard chow, AA5HT failed to affect intake. Therefore, indirectly activating parabrachial CB1 receptors by blocking the degradation of native ligands selectively stimulates the intake of palatable food, with differential actions on total energy intake depending upon the feeding schedule. Our results support a role for parabrachial cannabinoid mechanisms in providing physiological regulation to neural substrates modulating feeding, energy balance and behavioral responses for natural reward.
INTRODUCTION
Cannabinoid mechanisms have been widely reported to be involved in the regulation of feeding and energy balance (17) . The endocannabinoid system, which includes native ligands (endocannabinoids) (5, 18, 27) , their receptors (4, 20) and proteins modulating synthesis and degradation (25) , has been found throughout the central nervous system and in the periphery. Evidence suggests that central endocannabinoids play an important role in modulating food intake (6, 14, 26) .
Nonetheless, specific brain sites and mechanisms for their central actions contributing to the physiological control of feeding and energy balance are only beginning to be elucidated. Infusion of cannabinoid receptor agonists into several areas of the forebrain, including the nucleus accumbens shell (14, 26) and multiple nuclei of the hypothalamus (1, 11, 28) , increased consumption of standard chow. Similarly, endocannabinoids administered into the fourth ventricle of the hindbrain increased feeding when a more palatable diet of sweetened condensed milk was used (19) . Ventricular administration, however, fails to reveal specific loci in the brainstem where agonists act. Further, no studies have directly compared the influence of test diet on the actions of endocannabinoids in the hindbrain on feeding
We have reported the presence and functional capacity of CB1 receptors (CB1Rs) in the parabrachial nucleus to couple to their G-proteins, in vitro, following incubation of tissue sections with the endocannabinoid, 2-arachidonoylglycerol (7) . Furthermore, we have demonstrated that parabrachial infusions of 2-arachidonoylglycerol stimulated feeding. The actions of the endocannabinoid were selective for palatable foods, including fat and/or sugar, as 2-arachidonoylglycerol failed to affect intake of standard rodent chow. In addition, the actions of 2-arachidonoyl glycerol were anatomically specific, as off-target anatomical controls with infusions ~500µm caudal to those that successfully stimulated feeding, failed to affect the intake of the palatable food. These results suggested that hedonically-positive sensory properties of food enable endocannabinoids at parabrachial CB1Rs to initiate feeding.
The parabachial nucleus serves a role, though not exclusively, in gating gustatory neurotransmission and communicates this information with many brain regions controlling feeding behavior, including hypothalamic nuclei regulating energy balance and ventral striatal regions associated with reward (8, 16, (21) (22) (23) . Therefore, parabrachial CB1Rs may provide an additional layer of regulation to the neural substrates modulating feeding, energy balance and behavioral responses for natural reward.
Recent identification of proteins that modulate endocannabinoid synthesis and degradation (25) has led to indirect pharmacological approaches for investigating physiological roles for endocannabinoid mechanisms in feeding. Indeed, pharmacologically inhibiting one of the endocannabinoid degradative enzymes, fatty acid amide hydrolase (FAAH), by administering the FAAH inhibitor, arachidonoyl serotonin (AA5HT), into the nucleus accumbens shell increased the intake of standard chow (26).
The selective CB1R antagonist, AM251, blocked this increase, thereby implicating CB1Rs in the orexigenic responses to AA5HT.
The present series of studies characterized potential physiological roles for cannabinoid mechanisms in the parabrachial nucleus in modulating food intake.
Specifically, we infused AA5HT into this brainstem site to compare the effects of CB1R activation in modulating the intakes of hedonically-positive (pellets high in fat and sucrose) or hedonically-neutral (standard rodent chow) foods. We also tested the prediction that pretreatment with AM251 would block any orexigenic action of FAAH inhibition to indirectly stimulate these receptors in the parabrachial nucleus. We report a robust increase in the consumption of a test diet high in fat and sucrose content, but not of standard chow after parabrachial FAAH inhibition. This effect was prevented by CB1R blockade.
MATERIALS AND METHODS

Animals. Thirty-two male Sprague-Dawley rats (Taconic Farms, Germantown, NY)
weighing between 300 and 375g at time of surgery were used for these experiments. Experimental procedure. Experiments began following one week of daily habituation to the feeding schedules. At this time, baseline intakes were stable and did not vary by more than 10% during the last three days of this habituation. Following infusion of vehicle or test compound (1000 hrs), standard pelletized rodent chow [3.34kcal/g (12% kcal from fat, 28% protein, 60% carbohydrate); Purina 5001, St. Louis, MO] was removed from the home cages and replaced with pre-weighed quantities (30g) of high-fat/sucrose pellets [5.56kcal/g (58% kcal from fat, 16% protein, 26% carbohydrate); Research Diets #D12331; New Brunswick, NJ]. Animals were given access to the test diet for 4hr, then upon completion of the 4-hr test, remaining food was removed and replaced with free access to 60g of standard chow for the subsequent 20hr of the day and this schedule was repeated until the end of the study (for 3 days following infusion of test compounds). The same feeding schedule was used in a separate group of animals to test the ability for the CB1R antagonist, AM251, to block the hyperphagic responding to AA5HT. For the next group of animals, the feeding schedule was reversed and animals were given 4-hr access to standard chow, then high-fat/sucrose pellets for the ensuing 20hr. To test the dietselective effects of AA5HT, two more groups of animals were given free access to either high-fat/sucrose pellets or standard chow for the length of the study. All test diets were simply placed on the floor in the front of the cage. Intakes, adjusted for spillage, were measured at 4hr and 24hr following infusion of the test compound.
AA5HT, at a dose of ~2nmol/side, has been reported to stimulate feeding of standard chow when infused into the nucleus accumbens of rats (26). We chose this dose of AA5HT (2nmol) for testing the behavioral responses to inactivating parabrachial FAAH on 4-hr intakes of high-fat/sucrose pellets. The 2nmol dose failed to alter intake of the test-diet when compared to baselines obtained after vehicle infusion 24hrs earlier (n=4; means ± SEM; from 58.7±10.5 to 57.5±6.0 kcal). Therefore, we increased the dose of AA5HT infused to 4nmol and monitored the animals' subsequent 4-hr high-fat/sucrose intakes. This test was conducted three days following that with the lower dose. We found a robust increase in the consumption of the test diet during the 4-hr test when compared to vehicle treatment 24hrs earlier (means ± SEM; from 54.8±5.9 to 90.8±7.8 kcal;
p=0.01, Student's t-test for repeated measures). Thus, we chose to analyze the actions of this dose in all subsequent experiments. Histology. Upon completion of all experiments, animals were sacrificed by guillotine, brains removed and blocked to isolate the hindbrain, then immediately frozen to -18º C.
Thirty-µm sections were obtained containing the infusion site, then mounted on slides.
Slides containing the tissue sections were projected onto templates of coronal sections of the brain with a Camera Lucida (Bausch and Lomb, Rochester, NY, USA) for anatomical verification. The white outline in Figure 1 indicates the boundaries in which the injector tips were located for infusion.
Statistical analysis. For experiments where animals were given 4-hr access to either highfat/sucrose pellets or standard chow (then reversed for the subsequent 20hrs), statistical comparison of conditions (vehicle and AA5HT) at days following infusion (0, 1, 2 and 3)
were analyzed by ANOVA separately for 4-hr intakes and for subsequent 20-hr intakes.
The same statistical analysis was made for the group receiving AM251 and AA5HT, except the conditions included: vehicle, AA5HT, AM251, AA5HT and AM251 together.
For the experiments investigating diet-selective effects for AA5HT when animals had free access to either high-fat/sucrose pellets or standard chow, 4-hr and 24-hr cumulative intakes were separately analyzed by ANOVA at days following infusion as mentioned above. Post-hoc evaluations were made for comparison among means by Student-Newman-Keuls test. An alpha level of p<0.05 was the threshold for significance for all statistical tests.
RESULTS
Immunofluorescence identifies the presence of FAAH throughout the parabrachial nucleus
FAAH-like immunoreactivity can be seen throughout the parabrachial nucleus ( Figure 1) and is absent when the primary antibody is left out of the incubation medium (Figure 1 To test potential diet-selective actions for AA5HT in the parabrachial nucleus, we gave separate groups of animals ad libitum access to either high-fat/sucrose pellets or standard chow. AA5HT stimulated high-fat/sucrose intake during the 4hr test period 
Orexigenic feeding responses to AA5HT are mediated by CB1Rs
In a similar manner to the feeding responses in Figure 
DISCUSSION
In this report, we manipulated endogenous mechanisms to evaluate potential physiological roles in feeding for the endocannabinoid system in the parabrachial nucleus of rats. Parabrachial infusion of the FAAH inhibitor, AA5HT, increased the consumption of a palatable high-fat/sucrose diet when compared with the intake of standard chow.
These actions were indirectly mediated through CB1Rs as evidenced by the complete blockade of the orexigenic responses with a selective CB1R antagonist. Importantly, animals were able to maintain their total 24hr caloric intake at baseline levels by compensating for their orexigenic responses to the palatable food with decreases in the intake of standard chow when presented for the subsequent 20hrs. These feeding responses to AA5HT occurred again the next day when presented with the same feeding schedule. This is in contrast to when the palatable diet was presented for 20hrs or more during testing. Interestingly, under these conditions, animals overconsumed their total 24hr caloric intake, though only on the day of infusion. Therefore, the actions of AA5HT in the parabrachial nucleus appear to be determined by the properties of the diet. In addition, the amount of time animals have access to the diets influences total caloric consumption and the time until regulation of overall caloric intake is re-established.
Directly activating CB1Rs in discrete brain loci has been reported previously to increase feeding. Few analyses, however, have been performed regarding the influence of the test diet on this orexigenic action. Koch and Matthews (15) reported that infusions of the natural cannabinoid receptor agonist, ∆ 9 tetrahydrocannabinol, into the lateral ventricles of rats increased the intake of a chocolate cake batter over standard rodent chow. This might imply that cannabinoid receptors in the forebrain selectively enhance the consumption of palatable foods. However, administration of cannabinoid agonists into discrete loci in the nucleus accumbens and hypothalamus (1, 11, 14, 26, 28 ) did increase intake of standard chow; palatable foods were not tested. In contrast, fourth ventricular infusion of a CB1R agonist enhanced the intake of sweetened condensed milk (19) .
We observed that discretely targeting parabrachial CB1Rs by infusing 2arachidonoyl glycerol specifically increased the intake of hedonically-positive diets (7) .
The present study, by using an inhibitor of the degradation of endogenous cannabinoids, strongly implicates a physiological role for these fatty acid derivatives in the parabrachial nucleus in controlling consumption of desirable foods.
The novel strategy to use enzyme inhibitors for investigating physiological roles for the endocannabinoid system in discrete brain loci in feeding has been reported only once in a study involving the nucleus accumbens in rats (26). In that study, directly activating CB1Rs with the endocannabinoid, anandamide, or indirectly, by blocking the FAAH-mediated enzymatic degradation of endocannabinoids in the nucleus accumbens of rats with AA5HT, increased the intake of standard chow on the day of infusion. The actions of the FAAH inhibitor were correlated with elevated local concentrations of endocannabinoids. Although AA5HT has no direct actions at CB1Rs (2), orexigenic responding to the inhibitor was blocked by central co-administration with AM251, thereby implicating CB1Rs in the feeding responses to FAAH inactivation. That investigation, however, failed to analyze in detail either the temporal components of the actions of AA5HT or the effect of diet on these responses.
We report differential actions on total energy intake for inactivating parabrachial FAAH depending upon the feeding schedule. When the feeding schedule consisted of high-fat/sucrose pellets for extended periods of time (ie., 20hrs or more), animals were unable to regulate their total energy intake as they did when given access to the palatable diet for only 4hr. Thus, 24-hr caloric intakes increased. This energy imbalance occurred only on the day of AA5HT infusion. It is plausible that the hedonic value of the test diet superseded the brake of homeostatic regulatory processes under these feeding schedules.
Subsequently, homeostatic mechanisms orchestrated by the hypothalamus, or other regions, overrode the hedonically-driven feeding and re-established baseline levels of intake on the following day. A regulatory imbalance did not occur when animals were presented with high-fat/sucrose pellets for only 4hr daily, as the rats compensated calorically by decreasing their subsequent 20hr intake of standard chow. In all of these studies, one possibility for the orexigenic action of the parabrachial endocannabinoids is that these fatty acid derivatives enhanced the reinforcing characteristics of the palatable food. As a consequence, responding for the desirable flavor or somatosensory properties of the diet was maintained at a higher level during the meal.
AA5HT has been reported to be a tightly binding, non-covalent inhibitor of FAAH in vitro (2) . This suggests that in our study, AA5HT still inhibits FAAH the day following infusion. It is possible, though highly unlikely, that the feeding schedules themselves altered FAAH expression and therefore sensitivity to pharmacological inactivation. Instead, it is more likely that the properties of the test diet dictated whether endocannabinoid levels, which were presumably elevated, acted to increase food consumption. These biochemical issues remain to be evaluated in future studies.
CB1Rs of the parabrachial nucleus appear to selectively modulate the intake of foods with hedonically-positive sensory properties. This role aligns with the known functions for the parabrachial nucleus which include, but are not limited to, the gating of gustatory neurotransmission derived from the tongue and mouth. This information reaches the parabrachial nucleus via Cranial Nerves X, IX and VII and is transmitted to other brain regions for processing (3, 9, 10, 23) . These areas include multiple brain sites modulating feeding, including the hypothalamus, amygdala and the ventral striatum. Of particular relevance, ventral striatal regions have been proposed to assign reward value to the afferent sensory information transmitted by the parabrachial nucleus (22). Gustatory neurotransmission in the parabrachial nucleus involves the waist region across the brachium conjunctivum and columns of cells bordering this structure in both lateral and medial aspects of the nucleus (12, 13, 24) . It is likely that our infusions of 0.5µl into the central lateral region (Figure 1 ) diffused and accessed substantial portions of the gustatory parabrachial nucleus. Therefore, our results suggest that parabrachial endocannabinoid mechanisms may assume a modulatory role in transmitting information associated with the sensory properties of foods to the mentioned regions in the forebrain.
PERSPECTIVES AND SIGNIFICANCE
Understanding the mechanisms that govern the choice of food on the basis of its oral stimulus properties and post ingestive consequences is critical if we are to develop novel, effective therapies for treating and preventing energy imbalance leading to obesity.
Scientific evidence has existed for several decades implicating cannabinoids in stimulating food intake in human and non-human animals. Furthermore, anecdotal and increasingly empirical evidence has established a role for these compounds in enhancing consumption of foods palatable foods. Often, of course, these foods are calorically dense.
The present studies demonstrate a role for endocannabinoids in the parabrachial nucleus in specifically promoting the intake of such desirable foods. In the past, major attention has been given to sites within the forebrain for this function. By identifying a region of the pontine brainstem in food selection, our data add to the anatomical range of the network that influences hedonically-based eating. Moreover, we show that endocannabinoids serve this physiological function in the brainstem. This function may involve mechanisms of reward.
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